all report title image

ATOPIC DERMATITIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Atopic Dermatitis Market, By Drug Class (Corticosteroids, Emollients/Moisturizers, IL-4 & PDE4 Inhibitors, Calcineurin Inhibitors Antibiotics, and Other Drug Classes), By Type of Administration (Topical, Oral, and Injectable), By Prescription Type (Over-the-counter (OTC) and Prescription), and By Geography (North America, Europe, Asia Pacific, Middle East and Africa, and Latin America)

  • Published In: 01 Apr, 2026
  • Code: CMI712
  • Page number: 170
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Class
      • Market Snapshot, By Type of Administration
      • Market Snapshot, By Prescription Type
      • Market Snapshot, By Geography
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Rise in prevalence of atopic dermatitis worldwide
      • Adverse effects of certain therapeutic drugs
      • Increase in demand for safe/effective treatments
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Atopic Dermatitis Market, By Drug Class, 2022-2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Emollients/Moisturizers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • IL-4 & PDE4 Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Calcineurin Inhibitors Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Other Drug Classes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
  5. Global Atopic Dermatitis Market, By Type of Administration, 2022-2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
  6. Global Atopic Dermatitis Market, By Prescription Type, 2022-2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Over-the-counter (OTC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Prescription
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
  7. Global Atopic Dermatitis Market, By Geography, 2022-2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
  8. Competitive Landscape

    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Nestle
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • LEO Pharma AS
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Encore Dermatology Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Allergan PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Regeneron Pharmaceuticals Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bausch Health Companies Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Analyst Views
  9. Section

    • Research Methodology
    • About us
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.